Differences in hormone therapy for patients with advanced metastatic prostate cancer from pronounce assess Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Prof Axel Merseburger speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference (IGILUC) in Cairo about the differences between the multiple forms of androgen deprivation therapy (ADT) that are available. nnProf Merseburger explains the advantages and disadvantages associated with the use of LHRH agonists versus LHRH antagonists and how these can be applied to the clinic. nnHe also mentions the PRONOUNCE trial, which aims to assess the occurrence of cardiova
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)